|Day Low/High||184.74 / 186.00|
|52 Wk Low/High||124.09 / 186.25|
The addition of Hospira's IV pumps, solutions, and devices business to ICU Medical's existing portfolio creates a leading pure-play infusion therapy company with focus and global scale
ICU Medical will pay $900 million for the infusion therapy unit rather than $1 billion.
The health care sector has been a miserable performer lately -- but these five health trades are bucking the trend.
The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 296,246 share increase in total short interest for ICU Medical, Inc. , to 828,440, an increase of 55.67% since 10/14/2016.
In recent trading, shares of ICU Medical, Inc. have crossed above the average analyst 12-month target price of $142.50, changing hands for $142.80/share.
ICU Medical (ICUI) purchased Pfizer's (PFE) infusion therapy business for $1 billion,
Stocks hold mixed on Thursday afternoon as crude oil enjoys another rally and Wall Street looks toward the Friday release of the monthly jobs report.
The addition of Hospira's IV pumps, solutions, and devices business to ICU Medical's existing portfolio will create a leading pure-play infusion therapy company
Trade-Ideas LLC identified ICU Medical (ICUI) as a strong and under the radar candidate
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.